WallStreetZenWallStreetZen

NASDAQ: TCON
Tracon Pharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

TCON past revenue growth

How has TCON's revenue growth performed historically?
Company
N/A
Industry
144.63%
Market
17.55%
TCON's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TCON's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance

TCON earnings and revenue history

Current Revenue
$12.0M
Current Earnings
-$3.6M
Current Profit Margin
-29.8%

TCON Return on Equity

Current Company
N/A
Current Industry
-63.5%
Current Market
188%

Be the first to know when TCON announces earnings.

TCON Return on Assets

Current Company
-35.9%
Current Industry
2.9%
TCON is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

TCON Return on Capital Employed

Current Company
-4,825.97%
Current Industry
19.5%
TCON's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TCON vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
TCON$12.05M$3.75M-$3.59M+32.05%N/A
GNPX$0.00-$30.85M-$30.86MN/AN/A
SEEL$2.20M-$37.75M-$37.88M+55.68%N/A
ADTX$645.18k-$27.64M-$32.70M+147.84%N/A
ENSC$0.00-$10.26M-$10.63MN/AN/A
View Top Biotech Stocks

TCON earnings dates

Next earnings date
May 8, 2024

Tracon Pharmaceuticals Earnings & Revenue FAQ

What were TCON's earnings last quarter?

On Invalid Date, Tracon Pharmaceuticals (NASDAQ: TCON) reported Q4 2023 earnings per share (EPS) of $0.40, up 106.45% year over year. Total Tracon Pharmaceuticals earnings for the quarter were $439.00 thousand. In the same quarter last year, Tracon Pharmaceuticals's earnings per share (EPS) was -$6.20.

If you're new to stock investing, here's how to buy Tracon Pharmaceuticals stock.

What was TCON's earnings growth in the past year?

As of Q2 2024, Tracon Pharmaceuticals's earnings has grown year over year. Tracon Pharmaceuticals's earnings in the past year totalled -$3.59 million.

What is TCON's earnings date?

Tracon Pharmaceuticals's earnings date is Invalid Date. Add TCON to your watchlist to be reminded of TCON's next earnings announcement.

What was TCON's revenue last quarter?

On Invalid Date, Tracon Pharmaceuticals (NASDAQ: TCON) reported Q4 2023 revenue of $3.05 million up Infinity% year over year. In the same quarter last year, Tracon Pharmaceuticals's revenue was $0.00.

What was TCON's revenue growth in the past year?

As of Q2 2024, Tracon Pharmaceuticals's revenue has grown null year over year. Tracon Pharmaceuticals's revenue in the past year totalled $12.05 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.